The world is now moving towards a more private setting of medical diagnosis, with rising understanding of immunology and biosensors. The home testing kits are a convenient and reliable option for the diagnosis of chronic & infectious diseases.

Market Outlook

The market is predicted to grow 6%, and by 2034 the market size will be $12.3B.

The Market Drivers

• Personalized care: Self-monitoring is becoming the favored choice
• Technology Innovations: Improved Accuracy and Convenience
• Post-Covid shift: The pandemic has normalized self-testing

Challenges

• Complex process for regulatory approvals
• Accuracy Concerns

Start-ups Paving the Way

• Hertility Health, which manufactures hormone-based fertility tracking devices, and Daye, which tracks the vaginal flora, have both contributed to the much-needed privacy of feminine health monitoring kits
• Newfoundland Diagnostics provides retail-accessible diagnostic testing for complex diseases such as thyroid and renal tests

How Can Effectual Help?

We enable R&D leaders, Technology Scouts, & Open Innovation Teams by providing information that can help them take real time business decisions backed with credible & authentic data.

• Technology & Business Landscape
• Innovation Scouting & Opportunity Assessment
• IP Research & Competitive Intelligence
• R & D Support, Portfolio & white space analysis